Invasive lobular breast cancer and its variants: How special are they for systemic therapy decisions?  Séverine Guiu, Anita Wolfer, William Jacot, Pierre.

Slides:



Advertisements
Similar presentations
The Good Fat Cell Volume 147, Issue 7, (December 2011) DOI: /j.cell Copyright © 2011 Terms and Conditions Terms and Conditions.
Advertisements

Perimenopausal migraine in women with vasomotor symptoms E. Anne MacGregor Maturitas Volume 71, Issue 1, Pages (January 2012) DOI: /j.maturitas
Mobile health IT: The effect of user interface and form factor on doctor–patient communication Ole Andreas Alsos, Anita Das, Dag Svanæs International Journal.
The Survival Kit: Software to analyze survival data including possibly correlated random effects G. Mészáros, J. Sölkner, V. Ducrocq Computer Methods and.
Treatment of HER2 positive advanced breast cancer with T-DM1: A review of the literature María Teresa Martínez, José Alejandro Pérez-Fidalgo, Paloma Martín-Martorell,
Metastatic melanoma treatment: Combining old and new therapies Ryan J. Davey, Andre van der Westhuizen, Nikola A. Bowden Critical Reviews in Oncology /
Eribulin—A review of preclinical and clinical studies
Gastric cancer Critical Reviews in Oncology / Hematology
Umesh K. Narta, Shamsher S. Kanwar, Wamik Azmi 
Exercise issues in older cancer survivors
Natural products and complementary therapies for chemotherapy-induced peripheral neuropathy: A systematic review  Cloé Brami, Ting Bao, Gary Deng  Critical.
Novel targets in gastric and esophageal cancer
Ki67 in breast cancer: prognostic and predictive potential
Critical Reviews in Oncology / Hematology
Nicoletta Colombo, Martin Gore 
Volume 361, Issue 9352, Pages (January 2003)
Organization of the clinical activity of Geriatric Oncology: Report of a SIOG (International Society of Geriatric Oncology) task force  Silvio Monfardini,
Aromatase inhibitor-associated bone loss in breast cancer patients is distinct from postmenopausal osteoporosis  Peyman Hadji  Critical Reviews in Oncology.
Comparison of the efficacy and safety of single-agent and doublet chemotherapy in advanced non-small cell lung cancer in the elderly: A meta-analysis 
The case for wider use of recombinant factor VIII concentrates
A phase II study of weekly carboplatin and paclitaxel as first-line treatment of elderly patients with advanced ovarian cancer  Sandro Pignata, Enrico.
P53 mutations in triple negative breast cancer upregulate endosomal recycling of epidermal growth factor receptor (EGFR) increasing its oncogenic potency 
Sorafenib-based combination as a first line treatment for advanced hepatocellular carcinoma: A systematic review of the literature  Omar Abdel-Rahman,
Building the bridge between rhabdomyosarcoma in children, adolescents and young adults: The road ahead  J. Carlijn Van Gaal, Eveline S.J.M. De Bont, Suzanne.
Incidence and clinical impact of chemotherapy induced myelotoxicity in cancer patients: An observational retrospective survey  Lazzaro Repetto  Critical.
Amy M. Lin, Charles J. Ryan, Eric J. Small 
Mast cells in breast cancer angiogenesis
Genistein: Its role in metabolic diseases and cancer
Jonathan P. Evans, Paul A. Sutton, Boleslaw K. Winiarski, Stephen W
Rituximab, fludarabine, and cyclophosphamide versus fludarabine and cyclophosphamide for treatment of chronic lymphocytic leukemia: A systematic review.
Iron overload and chelation therapy in myelodysplastic syndromes
A systematic review and meta-analysis of clinical trials of bladder-sparing trimodality treatment for muscle-invasive bladder cancer (MIBC)  Giorgio Arcangeli,
Abhimanyu Ghose, Ria Kundu, Tahir Latif 
Critical Reviews in Oncology / Hematology
Her-2/neu gene amplification and over-expression in stomach and esophageal adenocarcinoma: From pathology to treatment  Judith Maresch, Sebastian F. Schoppmann,
P. Therasse, S. Carbonnelle, J. Bogaerts 
Olfa Baroudi, Amel Benammar-elgaaied 
Clinically useful prognostic factors in acute myeloid leukemia
Angiogenic inhibitors in gastric cancers and gastroesophageal junction carcinomas: A critical insight  Giuseppe Aprile, Elena Ongaro, Marzia Del Re, Stefania.
Impact of liposomal doxorubicin-based adjuvant chemotherapy on autonomy in women over 70 with hormone-receptor-negative breast carcinoma: A French Geriatric.
Thank God for Richard Dawkins?
Gwo Yaw Ho, Natasha Woodward, Jermaine I.G. Coward 
Critical Reviews in Oncology / Hematology
Molecular and serum markers in hepatocellular carcinoma: Predictive tools for prognosis and recurrence  Ashish Singhal, Muralidharan Jayaraman, Danny.
Primary renal carcinoid: Treatment and prognosis
Precision medicine in ALK rearranged NSCLC: A rapidly evolving scenario  Alfredo Addeo, Fabrizio Tabbò, Tim Robinson, Lucio Buffoni, Silvia Novello  Critical.
Recommendations from the Spanish Oncology Genitourinary Group for the treatment of patients with metastatic castration-resistant prostate cancer  Miguel.
Immunotherapy, an evolving approach for the management of triple negative breast cancer: Converting non-responders to responders  Mai F. Tolba, Hany A.
Gerhard J. Molderings  Critical Reviews in Oncology / Hematology 
The benefits and harms of breast cancer screening
Peter T. Simpson, Leonard M. Da Silva, Sunil R. Lakhani  Cancer Cell 
Ductal Carcinoma in Situ of the Breast
Noha Abd ElRahim Aboulhagag, Rana Fathy Torky, Sabah Ahmed Fadel 
I. F. Anwar, S. K. Down, S. Rizvi, N. Farooq, A. Burger, A. Morgan, M
Rodolfo Montironi, Ming Zhou, Cristina Magi-Galluzzi, Jonathan I
Gene therapy in haematology and oncology
Cysteine cathepsins (proteases)—On the main stage of cancer?
David A. Tuveson, John P. Neoptolemos  Cell 
Establishment of Italian national DNA database and the central laboratory: Some aspects  R. Biondo, F. De Stefano  Forensic Science International: Genetics.
Population data for SE33 locus in United Arab Emirates Arab population
James V. Alvarez, Denise Perez, Lewis A. Chodosh  Cancer Cell 
Thank God for Richard Dawkins?
Volume 143, Issue 6, (December 2010)
Determination of siblings: A special case report from Halle
Arlene Chan, Marc Buyse, Bin Yao  The Lancet Oncology 
N. Scaramozzino, P. Terrenoire, L. Baron 
Skin cancer epidemic in a wireless world
Increasing incidence of brain tumours in sparsely populated areas
Statistical aspects of familial searching
Volume 12, Issue 6, Pages (December 2007)
Presentation transcript:

Invasive lobular breast cancer and its variants: How special are they for systemic therapy decisions?  Séverine Guiu, Anita Wolfer, William Jacot, Pierre Fumoleau, Gilles Romieu, Franck Bonnetain, Maryse Fiche  Critical Reviews in Oncology / Hematology  Volume 92, Issue 3, Pages 235-257 (December 2014) DOI: 10.1016/j.critrevonc.2014.07.003 Copyright © 2014 Elsevier Ireland Ltd Terms and Conditions

Fig. 1 Morphological aspects of classic and pleomorphic invasive lobular carcinoma. (A) Invasive lobular carcinoma, classic type. (B)–(D) Invasive pleomorphic lobular carcinoma: pleomorphic atypical nuclei (A); loss of E-cadherin expression (C) (E-cadherin is expressed in normal ductal cells); and Ki-67 immunostaining (D). Critical Reviews in Oncology / Hematology 2014 92, 235-257DOI: (10.1016/j.critrevonc.2014.07.003) Copyright © 2014 Elsevier Ireland Ltd Terms and Conditions

Fig. 2 Flowchart of eligible studies. Critical Reviews in Oncology / Hematology 2014 92, 235-257DOI: (10.1016/j.critrevonc.2014.07.003) Copyright © 2014 Elsevier Ireland Ltd Terms and Conditions